Table 2.
Clinicopathologic Features of miR-423 Expression in SYSUCC Cohort
Variable | Low miR-423 expression (n = 79) | High miR-423 expression (n = 78) | P-value |
---|---|---|---|
Age, y, mean ± SEM | 53.08 ± 1.26 | 54.68 ± 1.13 | 0.35 |
TNM Stage | |||
I | 19 (24.05%) | 9 (11.54%) | < 0.01 |
II | 42 (53.16%) | 30 (38.46%) | |
III | 17 (21.52%) | 32 (41.03%) | |
IV | 1 (1.27%) | 7 (8.97%) | |
Tumor Size | |||
T1/2 | 64 (81.01%) | 51 (65.38%) | < 0.01 |
T3/4 | 15 (18.99%) | 27 (34.62%) | |
Nodes Pathologic | |||
N0 | 46 (58.23%) | 29 (37.18%) | 0.02 |
N>0 | 33 (41.77%) | 49 (62.82%) | |
Metastasis Pathologic | |||
M0 | 78 (98.73%) | 71 (91.03%) | 0.03 |
M1 | 1 (1.27%) | 7 (8.97%) |
Note: Values are n (%) unless otherwise indicated.